medigraphic.com

2019, Number 5

<< Back Next >>

Cir Cir 2019; 87 (5)

Closure of stage 2 macular hole with a low-dose intravitreal injection of perfluoropropane

González-Cortés JH, Olvera-Barrios A, Treviño-Rodríguez HA, González-Cantú JE, M-Hamsho J

Language: English
References: 14
Page: 564-567
PDF size: 185.55 Kb.


ABSTRACT

Background: Idiopathic macular holes (IMH) are common and affect central vision. We demonstrate the effectiveness of 0.2 ml intravitreal perfluoropropane (C3F8) in Stage-2 IMH. Case: A 61-year-old woman presented with blurred vision OD. Best-corrected visual acuity (BCVA) was 20/125 OD and 20/20 OS. Biomicroscopy of OD evidenced a Stage-2 IMH. Intravitreal C3F8 was injected and postural measures prescribed. Optical coherence tomography 1 week after revealed posterior vitreous detachment and vitreomacular traction resolution. Full anatomical and functional recovery was achieved at week 4 and remained stable during a 6-month follow-up (BCVA 20/20 OD). Conclusion: Intravitreal C3F8 as initial therapy for Stage 2 IMH represents a good alternative to vitrectomy for patients with IMH.


REFERENCES

  1. Takahashi A, Yoshida A, Nagaoka T, Takamiya A, Sato E, Kagokawa H, et al. Idiopathic full-thickness macular holes and the vitreomacular interface: a high-resolution spectral-domain optical coherence tomography study. Am J Ophthalmol. 2012;154:881-9200.

  2. Gass JD. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol. 1988;106:629-39.

  3. Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995;119:752-9.

  4. Benson WE, Cruickshanks KC, Fong DS, Williams GA, Bloome MA, Frambach DA, et al. Surgical management of macular holes: a report by the american academy of ophthalmology. Ophthalmology. 2001;108: 1328‑35.

  5. Eckardt C, Eckardt U, Groos S, Luciano L, Reale E. Entfernung der membrana limitans interna bei makulalöchern klinische und morphologische befunde. Der Ophthalmol. 1997;94 545-51.

  6. Panozzo G, Parolini B. Cataracts associated with posterior segment surgery. Ophthalmol Clin North Am. 2004;17:557-68, 6.

  7. Chen TC, Yang CH, Yang CM. Intravitreal expansile gas in the treatment of early macular hole: reappraisal. Ophthalmologica. 2012;228:159-66.

  8. Mori K, Saito S, Gehlbach PL, Yoneya S. Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment. Ophthalmology. 2007;114:127-33.

  9. Banker AS, Freeman WR, Kim JW, Munguia D, Azen SP. Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for macular hole study group. Ophthalmology. 1997; 104:1442-52.

  10. Chan CK, Wessels IF, Friedrichsen EJ. Treatment of idiopathic macular holes by induced posterior vitreous detachment. Ophthalmology. 1995; 102:757-67.

  11. Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, et al. The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013; 120:2611-9.

  12. Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol. 2010;149:371-820.

  13. Steel DH, Lotery AJ. Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment. Eye (Lond). 2013;27 Suppl 1:S1-21.

  14. McCannel CA, Ensminger JL, Diehl NN, Hodge DN. Population-based incidence of macular holes. Ophthalmology. 2009;116:1366-9.




2020     |     www.medigraphic.com